Glycothiohexides, novel antibiotics produced by "Sebekia" sp. LL-14E605. I. Taxonomy, fermentation and biological evaluation. 1994

D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
Natural Products Research Section, American Cyanamid Company, Pearl River, New York.

The new glycothiohexide antibiotics, which are related to nosiheptide, were identified in fermentations of an actinomycete belonging to the genus "Sebekia". Strain LL-14E605 was classified as a "Sebekia" based on the presence of both mesodiaminopimelic acid and madurose in the cell wall and the presence of pseudosporangia encasing the spores. Culture LL-14E605 was successfully fermented in 10 to 3,000 liters of a complex medium. Antibiotic activity closely followed cell mass accumulation and usually peaked after 4 to 5 days of incubation. Glycothiohexide alpha demonstrated excellent in vitro activity against Gram-positive bacteria with MICs of 0.03 to 0.06 microgram/ml against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. However, glycothiohexide alpha failed to protect mice against a lethal challenge with Staphylococcus aureus Smith unless it was administered prior to challenge.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000192 Actinomycetales An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments. Corynebacteriaceae,Coryneform Group
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
November 2001, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
May 2003, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
October 1983, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
May 2001, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
October 2006, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
August 1994, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
April 2002, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
March 1990, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
April 1997, The Journal of antibiotics,
D A Steinberg, and V S Bernan, and D A Montenegro, and D R Abbanat, and C J Pearce, and J D Korshalla, and N V Jacobus, and P J Petersen, and M J Mroczenski-Wildey, and W M Maiese
April 1996, The Journal of antibiotics,
Copied contents to your clipboard!